Uğur Şahin Announced that the BioNTech Vaccine is Very Effective Against the Delta Variant!
BioNTech founder Uğur Şahin made statements about coronavirus vaccines. Stating that the vaccine does not need to be updated, Şahin stated that the current vaccine is effective enough against the delta variant. Also, according to BioNTech, the highest protection is achieved after the third dose.
Uğur Sahin, the founder of the coronavirus vaccine developer BioNTech, which has been on the agenda with its last 3-month financial report published in the past hours, made some statements about the vaccine. Resolving an important question mark in people's minds, Sahin said that the coronavirus vaccine they developed is effective against the delta variant that is plaguing the world.
According to the statements made by Sahin, there is no situation that will require updating the current vaccine, at least for now. Stating that the vaccine may need to be updated in the next 6 to 12 months, Sahin stated that the update time is also very important, so they carefully examine each new variant reported.
According to BioNTech Company, the Best Application for Delta Variant Is 3 Doses!
Company officials, updating BioNTech's website, state that the most correct move in the vaccination process is three doses of vaccine. In other words, 3 doses of BioNTech vaccine currently provides the most effective protection against all variants of the coronavirus. This arrangement was also expressed by Uğur Sahin. In addition, laboratory studies are continuing on the vaccine to be given to children aged 6 months to 11 years.
Although Uğur Sahin says that the vaccine does not need to be updated, his company has already developed a vaccine that is effective only against the delta variant. This vaccine will begin to be administered to humans in a few days. If this vaccine proves to be as effective as desired, a new alternative vaccine for humans will be devised. The company is preparing to apply to international health authorities for the third dose with this vaccine.